157 related articles for article (PubMed ID: 34402680)
21. Second Primary Malignancies in Patients with Colorectal Cancer: A Population-Based Analysis.
Jia H; Li Q; Yuan J; Sun X; Wu Z
Oncologist; 2020 Apr; 25(4):e644-e650. PubMed ID: 31943509
[TBL] [Abstract][Full Text] [Related]
22. Clinical characteristics and overall survival nomogram of second primary malignancies after prostate cancer, a SEER population-based study.
Liu Y; Zhang P; Zhang Y; Zheng L; Xu W; Hou D; Kang Z
Sci Rep; 2021 Jan; 11(1):1293. PubMed ID: 33446816
[TBL] [Abstract][Full Text] [Related]
23. Epidemiological analysis of second primary malignant neoplasms in cancer survivors aged 85 years and older: a SEER data analysis (1975-2016).
Zhao X; Zhang L; Bai L; Zhao Y; Yang Q
Sci Rep; 2022 Jul; 12(1):11688. PubMed ID: 35803964
[TBL] [Abstract][Full Text] [Related]
24. Development and validation of nomograms for predicting survival of elderly patients with stage I small-cell lung cancer.
Yang Y; Sun S; Wang Y; Xiong F; Xiao Y; Huang J
Bosn J Basic Med Sci; 2021 Oct; 21(5):632-641. PubMed ID: 33577444
[TBL] [Abstract][Full Text] [Related]
25. Risk of second primary malignancy after non-small cell lung cancer: a competing risk nomogram based on the SEER database.
Zhou H; Shen J; Zhang Y; Huang Y; Fang W; Yang Y; Hong S; Liu J; Xian W; Zhang Z; Ma Y; Zhou T; Zhao H; Zhang L
Ann Transl Med; 2019 Sep; 7(18):439. PubMed ID: 31700875
[TBL] [Abstract][Full Text] [Related]
26. Incidence of second primary malignancy after breast cancer and related risk factors-Is breast-conserving surgery safe? A nested case-control study.
Li Z; Wang K; Shi Y; Zhang X; Wen J
Int J Cancer; 2020 Jan; 146(2):352-362. PubMed ID: 30861567
[TBL] [Abstract][Full Text] [Related]
27. Risks for noncutaneous second primary malignancy in cutaneous malignant melanoma survivors: an analysis of data from the Surveillance, Epidemiology, and End Results (SEER) program.
Vakharia PP; Kelm RC; Orrell KA; Patel KR; Singam V; Ali Y; Rastogi S; Yousif R; Rangel SM; West DP; Nardone B
Int J Dermatol; 2020 Apr; 59(4):463-468. PubMed ID: 31971260
[TBL] [Abstract][Full Text] [Related]
28. The Risk of Second Primary Malignancies in Patients With Lung Neuroendocrine Tumors: A Population-Based Study on SEER Database.
Bu X; Wang X; Wei L; Liu J; Chen M
Curr Probl Cancer; 2020 Dec; 44(6):100613. PubMed ID: 32563531
[TBL] [Abstract][Full Text] [Related]
29. Development and validation of a nomogram to predict synchronous lung metastases in patients with ovarian cancer: a large cohort study.
Yuan Y; Guo F; Wang R; Zhang Y; Bai G
Biosci Rep; 2020 Nov; 40(11):. PubMed ID: 33175143
[TBL] [Abstract][Full Text] [Related]
30. Incidence trends and risk prediction nomogram of metachronous second primary lung cancer in lung cancer survivors.
Hu ZG; Li WX; Ruan YS; Zeng FJ
PLoS One; 2018; 13(12):e0209002. PubMed ID: 30557376
[TBL] [Abstract][Full Text] [Related]
31. Risk of second primary malignancy in adults with pulmonary high-grade neuroendocrine carcinoma (HGNEC).
Wu X; Zhang X; Tao L; Chen P
BMC Cancer; 2020 Aug; 20(1):719. PubMed ID: 32746796
[TBL] [Abstract][Full Text] [Related]
32. Previous head and neck cancers portend poor prognoses in lung cancer patients.
Jayaprakash V; Cheng C; Reid M; Dexter EU; Nwogu CE; Hicks W; Sullivan M; Demmy TL; Yendamuri S
Ann Thorac Surg; 2011 Sep; 92(3):1056-60; discussion 1060-1. PubMed ID: 21871300
[TBL] [Abstract][Full Text] [Related]
33. Incidence and risk outcomes of second primary malignancy of patients with post-operative colorectal cancer.
Yang J; Wu F; An H; Gan H
Int J Colorectal Dis; 2023 Mar; 38(1):88. PubMed ID: 36995483
[TBL] [Abstract][Full Text] [Related]
34. Incidence and pattern of second primary malignancies in patients with index oropharyngeal cancers versus index nonoropharyngeal head and neck cancers.
Gan SJ; Dahlstrom KR; Peck BW; Caywood W; Li G; Wei Q; Zafereo ME; Sturgis EM
Cancer; 2013 Jul; 119(14):2593-601. PubMed ID: 23605777
[TBL] [Abstract][Full Text] [Related]
35. Risk of second primary malignancy after minor salivary gland cancer: A Surveillance, Epidemiology, and End Results database analysis.
Yang J; Wei R; Song X; Sun X; Wang H; Liu Q; Hu L; Yu H; Wang D
Head Neck; 2021 Jun; 43(6):1769-1779. PubMed ID: 33590552
[TBL] [Abstract][Full Text] [Related]
36. Factors for incidence risk and prognosis in non-small-cell lung cancer patients with synchronous brain metastasis: a population-based study.
Zhu H; Zhou L; Guo Y; Yang G; Dong Q; Zhang Z; Chen M; Yang Q
Future Oncol; 2021 Jul; 17(19):2461-2473. PubMed ID: 33706557
[TBL] [Abstract][Full Text] [Related]
37. Risk and subtypes of secondary primary malignancies in diffuse large B-cell lymphoma survivors change over time based on stage at diagnosis.
Major A; Smith DE; Ghosh D; Rabinovitch R; Kamdar M
Cancer; 2020 Jan; 126(1):189-201. PubMed ID: 31509235
[TBL] [Abstract][Full Text] [Related]
38. Association between socioeconomic factors at diagnosis and survival in breast cancer: A population-based study.
Ji P; Gong Y; Jiang CC; Hu X; Di GH; Shao ZM
Cancer Med; 2020 Mar; 9(5):1922-1936. PubMed ID: 31960597
[TBL] [Abstract][Full Text] [Related]
39. Trends of Second Primary Malignancy in Patients with Thyroid Cancer: A Population-Based Cohort Study in Israel.
Izkhakov E; Barchana M; Liphshitz I; Silverman BG; Stern N; Keinan-Boker L
Thyroid; 2017 Jun; 27(6):793-801. PubMed ID: 28338430
[TBL] [Abstract][Full Text] [Related]
40. Impact of latency time on survival for adolescents and young adults with a second primary malignancy.
Goldfarb M; Rosenberg AS; Li Q; Keegan THM
Cancer; 2018 Mar; 124(6):1260-1268. PubMed ID: 29205296
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
